Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Generative AI In Medicine Market Growth From $1.36 Billion In 2026 To $5.77 Billion By 2030 At A CAGR Of 43.4%
The generative AI in medicine market has seen rapid expansion in recent years. It is projected to increase from $0.95 billion in 2025 to $1.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 43.7%. The historical growth of this market can be attributed to advancements in medical imaging technologies, the increasing integration of AI within hospitals and clinics, a surge in clinical research initiatives, the growing demand for personalized medicine, and the development of electronic health record (ehr) enhancement tools.
The market for generative AI in medicine is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $5.77 billion, exhibiting a compound annual growth rate (CAGR) of 43.4%. This forecasted rise is primarily driven by the increasing application of AI-assisted solutions for drug discovery, the integration of generative AI into treatment planning processes, a surge in the utilization of virtual nursing assistants, the adoption of robot-assisted AI in surgical procedures, and the advancement in predictive patient data analytics. Key developments during this period are expected to include AI-driven diagnostic tools, personalized treatment strategies, virtual nursing assistants, robot-assisted AI surgery, comprehensive patient data analysis, and proactive healthcare models.
Get A Free Sample Report With In-Depth Market Insights:
Generative AI In Medicine Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The growing prevalence of digital health records is projected to drive the expansion of the generative artificial intelligence (AI) in medicine market. Digital health records, also known as electronic health records (EHRs), are organized digital repositories of patient health data designed to be shared across healthcare settings, thereby boosting the efficiency and quality of patient care. This increase in digital health records is attributed to advancements in patient care, greater efficiency in healthcare delivery, regulatory backing and incentives, technological innovations, and improved patient engagement and empowerment. Artificial intelligence (AI) in medicine enhances digital health records through automated documentation, data structuring, provision of predictive insights, and generation of personalized summaries, ultimately improving accuracy, accessibility, and overall patient care. For instance, in July 2024, the European Commission, a Belgium-based executive branch of the European Union, noted that the access to electronic health records score rose to 79% in 2024 from 72% in 2023. Consequently, the surge in digital health records is a key driver for the generative artificial intelligence (AI) in medicine market.
Generative AI In Medicine Market Segments: Where Is Growth Concentrated?
The generative AI in medicine market covered in this report is segmented –
1) By Component: Solutions, Service
2) By Function: Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis
3) By Application: Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, Other Applications
4) By End-User: Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End-Users
Subsegments:
1) By Solutions: Diagnostic Tools, Treatment Planning Systems, Personalized Medicine Platforms, Drug Discovery And Development Solutions, Medical Imaging And Analysis Software, Electronic Health Record (EHR) Enhancement Tools
2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Technical Support And Maintenance, Research And Development Services.
Generative AI In Medicine Market Innovation Trends Shaping Future Development
Major companies operating in the generative artificial intelligence (AI) in medicine market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, with the goal of advancing cognitive assessment, improving patient care, and enhancing overall mental health management. These AI solutions for brain health and wellness are sophisticated artificial intelligence technologies designed to evaluate, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company focused on developing AI-powered digital therapeutics, introduced CERVAI, which is the first AI solution for human mental health and wellness. This innovative solution leverages advanced artificial intelligence to comprehensively assess cognitive function and brain wellness. Its key features include cutting-edge algorithms that analyze diverse data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, enabling the early detection of cognitive issues and tailored interventions.
Generative AI In Medicine Market Key Participants And Competitive Landscape
Major companies operating in the generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.
View The Full Generative AI In Medicine Market Report:
Generative AI In Medicine Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
